40 completed, 7 withdrawn, 5 terminated, 5 unknown. 20 Not applicable, 16 Phase 2, 10 Phase 4, 9 Phase 1, 5 Early Phase 1.
Follow Petrolatum: new trials by email Literature Review of Petrolatum trials Research Report on Petrolatum
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Investigation of a Topical Moisturizer on Skin Barrier Function in Adults With Sensitive Skin White petrolatum, Investigational moisturizer - Sensitive Skin | Phase 4 | Recruiting | Good Molecules, LLC | 24 | 2026-09-14 | 2026-09-10 |
| Outcome of Hyaluronic Acid Gel Versus Petroleum Jelly in Treatment of Epistaxis Hyaluronic Acid Gel, Petroleum jelly - Epistaxis | Not applicable | Not yet recruiting | Assiut University | 50 | 2026-05-01 | 2026-04-22 |
| CO2Lift and T-Junction Breakdown Rates Evaluation After Breast Reduction Surgery Pilot Trial Carboxygel, Vaseline - Wound Breakdown, Breast Reduction | Not applicable | Not yet recruiting | University of Calgary | 10 | 2026-04-01 | 2026-02-13 |
| Immunotherapy After Transplantation for Skin Cancer Prevention in Organ Transplant Recipients Calcipotriol Only Product in Cutaneous Dose Form, Vaseline, Topical 5FU - Immunotherapy, Cutaneous Squamous Cell Carcinoma | Phase 2 | Withdrawn | Massachusetts General Hospital | 2026-01-01 | 2025-05-07 | |
| Nasal Packing After Turbinoplasty Standard bilateral Merocel® nasal tampons packing after Microdebrider-assisted inferior turbinoplasty, A Merocel® tampon was enclosed within the finger portion of a sterile powder-free latex surgical glove after Microdebrider-assisted inferior turbinoplasty, Merocel® tampons were coated with a thin uniform layer of topical broad-spectrum antibiotic ointment after microdebrider-assisted inferior turbinoplasty - Nasal Packing | Not applicable | Completed | Kafrelsheikh University | 135 | 2026-01-01 | 2026-06-23 |
| Immunotherapy Before Transplantation for Skin Cancer Prevention in Organ Transplant Recipients Calcipotriol Only Product in Cutaneous Dose Form, Vaseline, Topical 5FU - Cutaneous Squamous Cell Carcinoma, Actinic Keratoses | Phase 2 | Withdrawn | Massachusetts General Hospital | 2026-01-01 | 2025-05-07 | |
| Novel Skin Barrier Product Versus Petrolatum for Skin Barrier Dysfunction Novel barrier repair topical product, Petrolatum - Psoriasis, Atopic Dermatitis | Not applicable | Recruiting | Makati Medical Center | 26 | 2025-08-31 | 2025-09-19 |
| Skin Barrier Function and Inflammation in Aging: The BIA Study CeraVe Moisturizing Cream, Vaseline - Inflammation, Skin Inflammation | Phase 4 | Completed | University of California, San Francisco | 32 | 2025-02-06 | 2026-07-14 |
| StrataXRT for the Prevention and Treatment of Radiation Dermatitis in Breast Cancer or Head and Neck Cancer Patients Calendula Ointment, Petrolatum-Mineral Oil-Lanolin-Ceresin Ointment, Polyethylene Glycol Hydrogel - Breast Carcinoma, Head and Neck Carcinoma | Not applicable | Withdrawn | OHSU Knight Cancer Institute | 2024-01-01 | 2024-05-06 | |
| The Effect of Er,Cr:YSGG Laser-assisted Topical Anesthetic on Oral Mucosal Anesthesia Er,Cr:YSGG laser irradiation, Sham Laser irradiation, Lidocaine - Anesthesia | Early Phase 1 | Completed | Li Zhen Zhong | 20 | 2024-01-01 | 2025-12-04 |
| Diclofenac Gel in the Treatment of Cervicogenic Headache Diclofenac 1% Topical, Petroleum Jelly - Cervicogenic Headache | Phase 3 | Withdrawn | Loma Linda University | 2023-12-01 | 2025-01-23 | |
| Retrospective Cohort Study Comparing a Novel Gel Dressing vs SoC in the Treatment of Radiation Dermatitis StrataXRT, Calendula, Aquaphor - Radiation Dermatitis | Completed | Stratpharma AG | 344 | 2023-05-01 | 2024-02-01 | |
| StrataXRT Versus Aquaphor for the Prevention and Management of Radiation Dermatitis StrataXRT, Aquaphor - Radiation Dermatitis | Not applicable | Terminated | Stratpharma AG | 13 | 2022-11-01 | 2024-09-04 |
| Comparing Supplemental Topical Agents for the Treatment of Acute Radiation Dermatitis in Patients With Breast Cancer Agent Affecting Integumentary System, Petrolatum-Mineral Oil-Lanolin-Ceresin Ointment, Quality-of-Life Assessment - Breast Ductal Carcinoma In Situ, Invasive Breast Carcinoma | Phase 1 | Active not recruiting | City of Hope Medical Center | 208 | 2022-09-09 | 2026-08-17 |
| Topical Antibacterial Agents for Prevention of COVID-19 Neosporin, Vaseline - COVID-19, SARS-CoV2 Infection | Phase 1 | Completed | Yale University | 67 | 2022-09-01 | 2023-10-03 |
| Dermaprazole Cream for Radiation Dermatitis in Head and Neck Cancer Dermaprazole, Aquaphor - Cancer of the Head and Neck | Phase 2 | Completed | The University of Texas Health Science Center at San Antonio | 6 | 2022-06-15 | 2025-08-06 |
| Efficacy of Tazarotene in Treatment of Verruca Plana Tazarotene 0.1% Gel,Top, Imiquimod, Fluorouracil Cream - Warts Flat | Phase 2 | Unknown | Zagazig University | 80 | 2022-04-15 | 2022-05-16 |
| Photoallergic Potential of 6% Bemotrizinol 6% Bemotrizinol in sunscreen formulation, 6% Bemotrizinol in petrolatum, Vehicle - Photoallergic Response | Phase 2 | Completed | dsm-firmenich Switzerland AG | 50 | 2022-03-07 | 2022-08-26 |
| Phototoxicity Potential of 6% Bemotrizinol Sunscreen oil with 6% Bemotrizinol, Sunscreen oil vehicle, Dispersion of 6% BEMT in petrolatum - Phototoxic Response | Phase 2 | Completed | dsm-firmenich Switzerland AG | 34 | 2022-02-28 | 2022-08-26 |
| Dermal Irritation, Sensitization and Cumulative Irritation Potential of 6% Bemotrizinol 6% Bemotrizinol (BEMT) in a basic sunscreen oil formulation, 6% Bemotrizinol (BEMT) dispersion in petrolatum, Sunscreen oil vehicle with 10% ethanol as penetration enhancer without BEMT - Sunburn | Phase 2 | Completed | dsm-firmenich Switzerland AG | 224 | 2022-02-23 | 2022-08-26 |
Showing 20 of 62. Sign in to see all of them.
Dermatitis, Atopic (6) · Keratosis, Actinic (5) · Radiodermatitis (5) · Breast Neoplasms (3) · Eczema (3) · Skin Neoplasms (3) · Carcinoma, Squamous Cell (2) · Dermatitis (2) · Keloid (2) · Keratosis (2) · Psoriasis (2) · Surgical Wound (2) · COVID-19 (1) · Callosities (1) · Carcinoma, Intraductal, Noninfiltrating (1)
Healthpoint (3) · Massachusetts General Hospital (3) · dsm-firmenich Switzerland AG (3) · Mahidol University (2) · Stratpharma AG (2) · The University of Texas Health Science Center at San Antonio (2) · Zagazig University (2) · Ascension Health (1) · Assiut University (1) · Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh (1) · Biosplice Therapeutics, Inc. (1) · Birken AG (1) · City of Hope Medical Center (1) · Crouse Hospital (1) · Dana-Farber Cancer Institute (1)
United States (34) · Germany (3) · Bangladesh (2) · China (2) · Egypt (2) · Japan (2) · Thailand (2) · Brazil (1) · Canada (1) · Croatia (1) · Denmark (1) · Greece (1) · Indonesia (1) · Iran (1) · Mexico (1)
Gladys Osis, MT (2) · Herbert B Slade, MD (2) · Rolf Schutz, PhD (2) · Shadmehr Demehri, MD/PHD (2) · Ahmed AbdelAleem AbdelWahab, Prof (1) · Alice P Chen, M.D. (1) · Amy Paller, MD (1) · Ana M Aldea Perona, Dr (1) · Anna Grossberg, MD (1) · Carol Hlela, MD, PhD (1) · Charles Dela Cruz, MD (1) · Claus Garbe, Prof. Dr. (1) · Daniel Pearce (1) · Dean L Kellogg, Jr., MD, PhD (1) · Duc Tran, MD, PhD (1)
PMID 11934971, PMID 19403473, PMID 20001836, PMID 21059712, PMID 22934545, PMID 23402088, PMID 23494072, PMID 23554239, PMID 24054756, PMID 25053981, PMID 25124939, PMID 26054651, PMID 26151791, PMID 27869649, PMID 34023342, PMID 34039435, PMID 34121334, PMID 36302173
P30CA012197 (1), P30CA043703 (1), R21AG068731 (1), R21AR082620 (1)